Mativ Holdings, Inc.

NYSE:MATV Stock Report

Market Cap: US$678.7m

Mativ Holdings Valuation

Is MATV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MATV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MATV ($12.52) is trading above our estimate of fair value ($9.87)

Significantly Below Fair Value: MATV is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MATV?

Key metric: As MATV is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MATV. This is calculated by dividing MATV's market cap by their current revenue.
What is MATV's PS Ratio?
PS Ratio0.3x
SalesUS$1.97b
Market CapUS$678.65m

Price to Sales Ratio vs Peers

How does MATV's PS Ratio compare to its peers?

The above table shows the PS ratio for MATV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.6x
SIRE Sisecam Resources
0.7xn/aUS$511.9m
KOP Koppers Holdings
0.4x1.8%US$757.4m
OEC Orion
0.5x4.7%US$1.0b
WLKP Westlake Chemical Partners
0.7x6.7%US$796.2m
MATV Mativ Holdings
0.3x2.4%US$678.7m

Price-To-Sales vs Peers: MATV is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.5x).

Price to Sales Ratio vs Industry

How does MATV's PS Ratio compare vs other companies in the US Chemicals Industry?

10 CompaniesPrice / SalesEstimated GrowthMarket Cap
TSE Trinseo
0.03x5.0%US$117.53m
ALTO Alto Ingredients
0.1x3.1%US$106.54m
BON Bon Natural Life
0.2xn/aUS$5.36m
ABLT American Biltrite
0.02xn/aUS$2.91m
MATV 0.3xIndustry Avg. 1.4xNo. of Companies18PS01.22.43.64.86+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: MATV is good value based on its Price-To-Sales Ratio (0.3x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is MATV's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MATV PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.9x

Price-To-Sales vs Fair Ratio: MATV is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MATV forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$12.52
US$18.00
+43.8%
11.1%US$20.00US$16.00n/a2
Nov ’25US$15.59
US$24.50
+57.2%
22.4%US$30.00US$19.00n/a2
Oct ’25US$16.63
US$24.50
+47.3%
22.4%US$30.00US$19.00n/a2
Sep ’25US$18.96
US$24.50
+29.2%
22.4%US$30.00US$19.00n/a2
Aug ’25US$18.44
US$24.50
+32.9%
22.4%US$30.00US$19.00n/a2
Jul ’25US$15.99
US$24.50
+53.2%
22.4%US$30.00US$19.00n/a2
Jun ’25US$17.97
US$24.50
+36.3%
22.4%US$30.00US$19.00n/a2
May ’25US$18.00
US$24.50
+36.1%
22.4%US$30.00US$19.00n/a2
Apr ’25US$18.56
US$24.50
+32.0%
22.4%US$30.00US$19.00n/a2
Mar ’25US$17.60
US$24.50
+39.2%
22.4%US$30.00US$19.00n/a2
Feb ’25US$11.73
US$21.00
+79.0%
19.0%US$25.00US$17.00n/a2
Jan ’25US$15.31
US$21.00
+37.2%
19.0%US$25.00US$17.00n/a2
Dec ’24US$13.71
US$21.00
+53.2%
19.0%US$25.00US$17.00n/a2
Nov ’24US$12.80
US$28.50
+122.7%
5.3%US$30.00US$27.00US$15.592
Oct ’24US$14.26
US$28.50
+99.9%
5.3%US$30.00US$27.00US$16.632
Sep ’24US$16.61
US$28.50
+71.6%
5.3%US$30.00US$27.00US$18.962
Aug ’24US$17.91
US$28.00
+56.3%
7.1%US$30.00US$26.00US$18.442
Jul ’24US$15.12
US$28.00
+85.2%
7.1%US$30.00US$26.00US$15.992
Jun ’24US$14.83
US$28.00
+88.8%
7.1%US$30.00US$26.00US$17.972
May ’24US$19.09
US$35.00
+83.3%
2.9%US$36.00US$34.00US$18.002
Apr ’24US$21.47
US$35.00
+63.0%
2.9%US$36.00US$34.00US$18.562
Mar ’24US$26.03
US$35.00
+34.5%
2.9%US$36.00US$34.00US$17.602
Feb ’24US$27.33
US$35.50
+29.9%
9.9%US$39.00US$32.00US$11.732
Jan ’24US$20.90
US$36.50
+74.6%
12.3%US$41.00US$32.00US$15.312

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Trinseo

US$117.5m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

TSE

US$3.32

7D

-8.3%

1Y

-48.8%

CMOC Group

HK$167.3b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.76

7D

0%

1Y

37.8%

Chemtrade Logistics Income Fund

CA$1.4b

Offers industrial chemicals and services in Canada, the United States, and South America.

CGIF.F

CA$8.30

7D

5.2%

1Y

31.5%